PrimeRFP SCOUT · Federal Contract Recompete Brief

36C24E22N0188Genomic analysis — Infinity Biologix LLC

Infinity Biologix LLC holds $25.6M across 18 federal awards, concentrated at Department of Veterans Affairs (VA). This PIID sits alongside 2 related awards under parent 36C24E20D0028. PoP ended Sep 29, 2023 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Rpo East (36C24E)

Awarding office

Infinity Biologix LLC

Recipient

Sep 29, 2023

PoP end

$12.5M

Obligated

$12.5M

Potential

541380

NAICS

Q301

PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Infinity Biologix LLC — $90

Contract facts

Federal

Contract number36C24E22N0188

Also listed as36C24E-22-N-0188

Also listed as36C24E20D0028-36C24E22N0188

AgencyRpo East (36C24E)

Awarding officeRpo East (36C24E)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentInfinity Biologix LLC

CAGE8MSH6

UEINPUACRBK7TV9

NAICS541380

No full NAICS 541380 intel page yet. Browse NAICS intelligence

PSCQ301

Parent IDIQ / IDV36C24E20D0028

Place of performanceWASHINGTON DC

Pricing typeFirm Fixed Price

Extent competedNot Competed

PoP startSep 30, 2022

PoP end (current)Sep 29, 2023

Obligated$12.5M

Current value$12.5M

Potential value$12.5M

GENOMIC ANALYSIS is a federal award for Rpo East (36C24E) held by Infinity Biologix LLC. Estimated value $12.5M ($12.5M obligated). Current period of performance ends Sep 29, 2023. Place of performance: WASHINGTON DC.

Recompete timing

Public

● Past PoP end (1057 days ago)

Current PoP ended Sep 29, 2023 (1057 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Incumbent footprint

Public record

Infinity Biologix LLC — $25.6M obligated across 18 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).

% of firm-wide obligated ($25.6M) · all agencies

Department of Veterans Affairs (VA)$19.8M · 77%Department of Health and Human Services (HHS)$5.8M · 23%Department of Agriculture (USDA)$1K · 0%

Open full company profile →

Related awards

Same parent · incumbent

36C24E26N0049

LONG READ SEQUENCING SERVICES

$1.2M

Mar 1, 2027

36C24E26N0159

LONG READ SEQUENCING FOR MVP PROGRAM

$7.8M

Jun 30, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C24E22N0188?

36C24E22N0188 (Genomic analysis) is a Rpo East (36C24E) award with a potential value of $12.5M, currently held by Infinity Biologix LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C24E-22-N-0188?

36C24E-22-N-0188 is the dashed form of PIID 36C24E22N0188 (Genomic analysis), held by Infinity Biologix LLC. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C24E22N0188?

Rpo East (36C24E) awarded 36C24E22N0188 to Infinity Biologix LLC (potential $12.5M).

Who is the incumbent on 36C24E22N0188?

Infinity Biologix LLC is the incumbent with $25.6M across 18 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2023.

When does Infinity Biologix LLC’s 36C24E22N0188 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2023. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jun 26, 2026 · refreshed monthlyLatest procurement action Mar 16, 2026